Myriad Genetics (MYGN) EBITDA Margin Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 50.00 |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | 519.00 |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 136.00 |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 376.00 |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | -101.00 |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 235.00 |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | 93.00 |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | 352.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | -78.00 |
| 10 | Myriad Genetics | 294.22 Mn | 169.82 Mn | 137.60 Mn | -52.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.00 |
| Dec 31, 2025 | 1,580.00 |
| Sep 30, 2025 | -195.00 |
| Jun 30, 2025 | -13,722.00 |
| Mar 31, 2025 | -101.00 |
| Dec 31, 2024 | -255.00 |
| Sep 30, 2024 | 2,194.00 |
| Jun 30, 2024 | 4,470.00 |
| Mar 31, 2024 | 1,501.00 |
| Dec 31, 2023 | 1,339.00 |
| Sep 30, 2023 | -255.00 |
| Jun 30, 2023 | -5,203.00 |
| Mar 31, 2023 | -1,328.00 |
| Dec 31, 2022 | -256.00 |
| Sep 30, 2022 | 1,899.00 |
| Jun 30, 2022 | 105.00 |
| Mar 31, 2022 | 1,145.00 |
| Dec 31, 2021 | 248.00 |
| Sep 30, 2021 | 1,228.00 |
| Jun 30, 2021 | 6,756.00 |